About InnoCure Therapeutics
InnoCure Therapeutics is a company based in Seongnam-si (South Korea) founded in 2018 by Hye Dong Yoo. InnoCure Therapeutics offers products and services including Resume Writing Service, Cover Letter Service, and Sample Documents. InnoCure Therapeutics operates in a competitive market with competitors including Biological E, Vir Biotechnology, Vaxcyte, Cidara Therapeutics and Freeline, among others.
- Headquarter Seongnam-si, South Korea
- Founders Hye Dong Yoo
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name 글과 사람들
- Jurisdiction Na, Maharashtra, India
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of InnoCure Therapeutics
InnoCure Therapeutics offers a comprehensive portfolio of products and services, including Resume Writing Service, Cover Letter Service, and Sample Documents.
Provides professional resume creation for job applications
Assists in drafting effective cover letters for employment
Offers templates for resumes and letters to aid self-preparation
Funding Insights of InnoCure Therapeutics
Detailed funding history for InnoCure Therapeutics
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by InnoCure Therapeutics
Investment portfolio details for InnoCure Therapeutics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - InnoCure Therapeutics
Detailed financials for InnoCure Therapeutics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Innocure Therapeutics Comparisons
Peer comparison for InnoCure Therapeutics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of InnoCure Therapeutics
InnoCure Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biological E, Vir Biotechnology, Vaxcyte, Cidara Therapeutics and Freeline, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Vaccines and therapeutics for multiple diseases are developed and marketed.
|
|
| Locked | Locked | Locked |
Developer of therapeutics for the treatment of infectious diseases
|
|
| Locked | Locked | Locked |
Vaccines for infectious diseases are developed using cell-free protein synthesis.
|
|
| Locked | Locked | Locked |
Novel anti-infectives for bacterial and fungal infections are developed.
|
|
| Locked | Locked | Locked |
Gene therapy platform is developed for chronic disease treatments.
|
|
| Locked | Locked | Locked |
Prophylactic vaccines for infectious diseases are developed and advanced.
|
Detailed competitors of InnoCure Therapeutics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Innocure Therapeutics
Complete news archive for InnoCure Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about InnoCure Therapeutics
InnoCure Therapeutics was founded in 2018.
InnoCure Therapeutics is headquartered in Seongnam-si, South Korea. It is registered at Seongnam-si, Gyeonggi-do, South Korea.
Hye Dong Yoo is the current CEO of InnoCure Therapeutics. They have also founded this company.
InnoCure Therapeutics was founded in 2018 and is based in Seongnam-si, South Korea. Operations focus on the biotechnology sector, where small molecule-based drugs are developed to modify cellular functions and address pathogenic proteins. The flagship TDbUM platform targets the ubiquitin-proteasome system and autophagy pathways, enabling the degradation of undruggable proteins to support cellular homeostasis. Services emphasize therapeutic solutions for protein-related disorders.
InnoCure Therapeutics's top competitors include Vaxcyte, Serum Institute of India and Biological E.
InnoCure Therapeutics offers Resume Writing Service, Cover Letter Service, and Sample Documents.